Search hospitals > Kentucky > Louisville
UofL Health Medical Center Northeast
Claim this profileLouisville, Kentucky 40245
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
173 reported clinical trials
8 medical researchers
Summary
UofL Health Medical Center Northeast is a medical facility located in Louisville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. UofL Health Medical Center Northeast is involved with conducting 173 clinical trials across 382 conditions. There are 8 research doctors associated with this hospital, such as Richard L. Deming, Neal E. Dunlap, Rebecca Redman, MD, and Mohamed M. Hegazi.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Richard L. DemingMercy Medical Center - Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
173 reported clinical trials
240 drugs studied
Neal E. DunlapThe James Graham Brown Cancer Center at University of Louisville3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
16 reported clinical trials
38 drugs studied
Rebecca Redman, MDJames Graham Brown Cancer Center3 years of reported clinical research
Studies Cancer
Studies Squamous Cell Carcinoma
15 reported clinical trials
28 drugs studied
Mohamed M. HegaziThe James Graham Brown Cancer Center at University of Louisville1 year of reported clinical research
Studies Lymphoma
Studies Leukemia
10 reported clinical trials
33 drugs studied
Clinical Trials running at UofL Health Medical Center Northeast
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Bladder Cancer
Cancer
Bladder Carcinoma
Squamous Cell Carcinoma
Melanoma
Cutaneous Melanoma
Multiple Myeloma
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at UofL Health Medical Center Northeast?
UofL Health Medical Center Northeast is a medical facility located in Louisville, Kentucky. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. UofL Health Medical Center Northeast is involved with conducting 173 clinical trials across 382 conditions. There are 8 research doctors associated with this hospital, such as Richard L. Deming, Neal E. Dunlap, Rebecca Redman, MD, and Mohamed M. Hegazi.